Skip to main content
Top

Medical Oncology

Issue 12/2021

Content (10 Articles)

Cytostatic Therapy Original Paper

Bioymifi, a novel mimetic of TNF-related apoptosis-induced ligand (TRAIL), stimulates eryptosis

Mohammad A. Alfhili, Ahmed M. Basudan, Feda S. Aljaser, Ayed Dera, Jawaher Alsughayyir

Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line

Shiva Najjary, Reza Mohammadzadeh, Behzad Mansoori, Fatemeh Vahidian, Ali Mohammadi, Mohammad Amin Doustvandi, Vahid Khaze, Khalil Hajiasgharzadeh, Behzad Baradaran

Kidney Cancer Original Paper

The apoptotic efficacy of succinic acid on renal cancer cell lines

Goksu Kasarci, Baris Ertugrul, Elif Sinem Iplik, Bedia Cakmakoglu

Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor

Gouri Nair, G. N. S. Hema Sree, Ganesan Rajalekshmi Saraswathy, V. Lakshmi Prasanna Marise, T. P. Krishna Murthy

Colon Cancer Original Paper

Enhancement of Apo2L/TRAIL signaling pathway receptors by the activation of Klotho gene with CRISPR/Cas9 in Caco-2 colon cancer cells

Sibel Gunes, Merve Nur Soykan, Ayla Eker Sariboyaci, Onur Uysal, Tugba Semerci Sevimli

Breast Cancer Original Paper

The effects of chemotherapeutic drugs on PD-L1 gene expression in breast cancer cell lines

Misagh Majidi, Sahar Safaee, Mohammad Amini, Amir Baghbanzadeh, Khalil Hajiasgharzadeh, Shahriar Hashemzadeh, Siamak Sandoghchian Shotorbani, Ahad Mokhtarzadeh, Behzad Baradaran

Leukoplakia Review Article

Notch signaling in oral pre-cancer and oral cancer

Kumud Nigam, Ratnesh Kumar Srivastav

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine